Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New GPR119 receptor agonists patented by LG Life Sciences

Sep. 13, 2012

Eaton Scientific to develop non-hormonal transdermal patch for hot flashes

Sep. 12, 2012

Last patient completes treatment in phase IIb bremelanotide trial

Sep. 12, 2012

AstraZeneca discontinues development of candidate in obesity collaboration with Palatin

Sep. 10, 2012

Sanofi develops new 11-beta-HSD1 inhibitors for the treatment of diabetes

Sep. 10, 2012

Aileron Therapeutics reports on new therapeutic drug program

Sep. 10, 2012

Novel DGAT1 inhibitors synthesized by Merck & Co.

Sep. 10, 2012

FDA extends PDUFA date for Ravicti NDA

Sep. 6, 2012

NPS Pharmaceuticals updates plans for Natpara BLA

Sep. 6, 2012

Light study of Contrave experiences accelerated enrollment

Sep. 6, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...